Stay updated with breaking news from Oblte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Belite Bio (NASDAQ:BLTE – Get Rating) had its target price reduced by HC Wainwright from $58.00 to $55.00 in a report issued on Monday, The Fly reports. HC Wainwright also issued estimates for Belite Bio’s Q2 2023 earnings at ($0.18) EPS, Q3 2023 earnings at ($0.19) EPS, Q4 2023 earnings at ($0.21) EPS, FY2023 earnings […]
Belite Bio, Inc (NASDAQ:BLTE – Get Rating) – Research analysts at HC Wainwright issued their Q1 2024 EPS estimates for Belite Bio in a report released on Monday, June 5th. HC Wainwright analyst Y. Chen expects that the company will earn ($0.23) per share for the quarter. The consensus estimate for Belite Bio’s current full-year […]
Belite Bio (NASDAQ:BLTE – Get Rating) had its price target reduced by equities researchers at HC Wainwright from $58.00 to $55.00 in a research note issued on Monday, The Fly reports. HC Wainwright’s target price suggests a potential upside of 264.24% from the company’s previous close. HC Wainwright also issued estimates for Belite Bio’s Q1 […]
Belite Bio, Inc (NASDAQ:BLTE – Get Rating) was the recipient of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 27,200 shares, a decrease of 18.6% from the April 30th total of 33,400 shares. Based on an average daily volume of 11,900 shares, the […]
Shares of Belite Bio, Inc (NASDAQ:BLTE – Get Rating) were up 4.6% during mid-day trading on Wednesday . The company traded as high as $24.23 and last traded at $23.80. Approximately 4,581 shares were traded during mid-day trading, a decline of 55% from the average daily volume of 10,247 shares. The stock had previously closed […]